318 related articles for article (PubMed ID: 25573143)
1. N-terminal pro-B-type natriuretic peptide and the risk of stroke and transient ischaemic attack: the Rotterdam Study.
Portegies ML; Kavousi M; Leening MJ; Bos MJ; van den Meiracker AH; Hofman A; Franco OH; Koudstaal PJ; Ikram MA
Eur J Neurol; 2015 Apr; 22(4):695-701. PubMed ID: 25573143
[TBL] [Abstract][Full Text] [Related]
2. N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) Levels are Increased in Patients With Transient Ischemic Attack Accompanied by Nonfocal Symptoms.
Plas GJ; Jurg SD; Brusse-Keizer M; Dippel DW; Koudstaal PJ; den Hertog HM
J Am Heart Assoc; 2015 Dec; 4(12):. PubMed ID: 26672079
[TBL] [Abstract][Full Text] [Related]
3. Prediction of heart failure by amino terminal-pro-B-type natriuretic peptide and C-reactive protein in subjects with cerebrovascular disease.
Campbell DJ; Woodward M; Chalmers JP; Colman SA; Jenkins AJ; Kemp BE; Neal BC; Patel A; MacMahon SW
Hypertension; 2005 Jan; 45(1):69-74. PubMed ID: 15569851
[TBL] [Abstract][Full Text] [Related]
4. Amino-terminal pro-B-type natriuretic peptide improves cardiovascular and cerebrovascular risk prediction in the population: the Rotterdam study.
Rutten JH; Mattace-Raso FU; Steyerberg EW; Lindemans J; Hofman A; Wieberdink RG; Breteler MM; Witteman JC; van den Meiracker AH
Hypertension; 2010 Mar; 55(3):785-91. PubMed ID: 20083731
[TBL] [Abstract][Full Text] [Related]
5. Prediction of myocardial infarction by N-terminal-pro-B-type natriuretic peptide, C-reactive protein, and renin in subjects with cerebrovascular disease.
Campbell DJ; Woodward M; Chalmers JP; Colman SA; Jenkins AJ; Kemp BE; Neal BC; Patel A; MacMahon SW
Circulation; 2005 Jul; 112(1):110-6. PubMed ID: 15983245
[TBL] [Abstract][Full Text] [Related]
6. N-terminal pro-brain natriuretic peptide level determined at different times identifies transient ischaemic attack patients with atrial fibrillation.
Purroy F; Suárez-Luis I; Mauri-Capdevila G; Cambray S; Farré J; Sanahuja J; Piñol-Ripoll G; Quílez A; González-Mingot C; Begué R; Gil MI; Fernández E; Benabdelhak I
Eur J Neurol; 2014 Apr; 21(4):679-83. PubMed ID: 23800180
[TBL] [Abstract][Full Text] [Related]
7. NT-pro-BNP: A novel predictor of stroke risk after transient ischemic attack.
Rodríguez-Castro E; Hervella P; López-Dequidt I; Arias-Rivas S; Santamaría-Cadavid M; López-Loureiro I; da Silva-Candal A; Pérez-Mato M; Sobrino T; Campos F; Castillo J; Rodríguez-Yáñez M; Iglesias-Rey R
Int J Cardiol; 2020 Jan; 298():93-97. PubMed ID: 31272739
[TBL] [Abstract][Full Text] [Related]
8. N-terminal pro-B-type natriuretic peptide and stroke risk: the reasons for geographic and racial differences in stroke cohort.
Cushman M; Judd SE; Howard VJ; Kissela B; Gutiérrez OM; Jenny NS; Ahmed A; Thacker EL; Zakai NA
Stroke; 2014 Jun; 45(6):1646-50. PubMed ID: 24757103
[TBL] [Abstract][Full Text] [Related]
9. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
Kistorp C; Raymond I; Pedersen F; Gustafsson F; Faber J; Hildebrandt P
JAMA; 2005 Apr; 293(13):1609-16. PubMed ID: 15811980
[TBL] [Abstract][Full Text] [Related]
10. Increase in N-terminal pro-brain natriuretic peptide levels, renal function and cardiac disease in the oldest old.
Poortvliet R; de Craen A; Gussekloo J; de Ruijter W
Age Ageing; 2015 Sep; 44(5):841-7. PubMed ID: 26209786
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation.
Roldán V; Vílchez JA; Manzano-Fernández S; Jover E; Gálvez J; Puche CM; Valdés M; Vicente V; Lip GY; Marín F
Stroke; 2014 Mar; 45(3):696-701. PubMed ID: 24519407
[TBL] [Abstract][Full Text] [Related]
12. Soluble vascular cell adhesion molecule 1 and N-terminal pro-B-type natriuretic peptide in predicting ischemic stroke in patients with cerebrovascular disease.
Campbell DJ; Woodward M; Chalmers JP; Colman SA; Jenkins AJ; Kemp BE; Neal BC; Patel A; MacMahon SW
Arch Neurol; 2006 Jan; 63(1):60-5. PubMed ID: 16286536
[TBL] [Abstract][Full Text] [Related]
13. N-Terminal Pro-B-Type Natriuretic Peptide Is Related to Retinal Microvascular Damage: The Rotterdam Study.
Mutlu U; Ikram MA; Hofman A; de Jong PT; Klaver CC; Ikram MK
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1698-702. PubMed ID: 27339461
[TBL] [Abstract][Full Text] [Related]
14. Sex steroids, sex hormone-binding globulin and levels of N-terminal pro-brain natriuretic peptide in postmenopausal women.
Glisic M; Rojas LZ; Asllanaj E; Vargas KG; Kavousi M; Ikram MA; Fauser BCJM; Laven JSE; Muka T; Franco OH
Int J Cardiol; 2018 Jun; 261():189-195. PubMed ID: 29551255
[TBL] [Abstract][Full Text] [Related]
15. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease.
Bibbins-Domingo K; Gupta R; Na B; Wu AH; Schiller NB; Whooley MA
JAMA; 2007 Jan; 297(2):169-76. PubMed ID: 17213400
[TBL] [Abstract][Full Text] [Related]
16. N-Terminal Pro-B-Type Natriuretic Peptide and Subclinical Brain Damage in the General Population.
Zonneveld HI; Ikram MA; Hofman A; Niessen WJ; van der Lugt A; Krestin GP; Franco OH; Vernooij MW
Radiology; 2017 Apr; 283(1):205-214. PubMed ID: 27924720
[TBL] [Abstract][Full Text] [Related]
17. NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) and the Risk of Stroke.
Di Castelnuovo A; Veronesi G; Costanzo S; Zeller T; Schnabel RB; de Curtis A; Salomaa V; Borchini R; Ferrario M; Giampaoli S; Kee F; Söderberg S; Niiranen T; Kuulasmaa K; de Gaetano G; Donati MB; Blankenberg S; Iacoviello L;
Stroke; 2019 Mar; 50(3):610-617. PubMed ID: 30786848
[TBL] [Abstract][Full Text] [Related]
18. N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation).
Hijazi Z; Wallentin L; Siegbahn A; Andersson U; Christersson C; Ezekowitz J; Gersh BJ; Hanna M; Hohnloser S; Horowitz J; Huber K; Hylek EM; Lopes RD; McMurray JJ; Granger CB
J Am Coll Cardiol; 2013 Jun; 61(22):2274-84. PubMed ID: 23563134
[TBL] [Abstract][Full Text] [Related]
19. Plasma natriuretic peptides and incidence of subtypes of ischemic stroke.
Berntsson J; Zia E; Borné Y; Melander O; Hedblad B; Engström G
Cerebrovasc Dis; 2014; 37(6):444-50. PubMed ID: 25060145
[TBL] [Abstract][Full Text] [Related]
20. N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in a Japanese community: the Hisayama study.
Doi Y; Ninomiya T; Hata J; Hirakawa Y; Mukai N; Ikeda F; Fukuhara M; Iwase M; Kiyohara Y
Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):2997-3003. PubMed ID: 21921261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
